When traditional AI meets quantum insight, the result is a system that understands uncertainty, adapts to biological complexity, and learns with depth.
Curious how we’re doing it? Our latest investor deck offers a comprehensive overview of QuantarMed’s transformative mission, market potential, technical breakthroughs, scalable product roadmap, and forward-looking revenue strategy.
QuantarMed is an HMRC-approved SEIS company, currently raising £250,000 under the UK’s Seed Enterprise Investment Scheme (SEIS). This allows early-stage investors to benefit from exceptional tax reliefs while supporting breakthrough innovation in healthcare.
We are now progressing into the Enterprise Investment Scheme (EIS), with capacity to raise up to £12 million in total. Upon being classified as a Knowledge-Intensive Company (KIC), that threshold increases to £20 million in total.
This is a rare opportunity to invest in a frontier-tech company fusing quantum intelligence with medical precision, backed by robust UK government incentives and built for global scale.
For investor enquiries,
Send us a message or call us at: investors@quantarmed.com
+44 7463 250140
.gif)
Our quantum-enhanced AI transcends traditional diagnostics, decoding the unique quantum signatures that define individual health patterns.
© 2025 QuantarMed Ltd. Company Number: 15897024. All rights reserved. Registered in England & Wales.
London, UK
.gif)
